Seminars in Nephrology
Volume 24, Issue 4 , Pages 299-315 , July 2004

Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health

  • Bruce C Kone

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Bruce C. Kone, MD, FACP, FCP, FAHA, Division of Renal Diseases and Hypertension, The University of Texas Health Sciences Center at Houston, 6431 Fannin, MSB 4.138, Houston, TX 77030 USA
    • Division of Renal Diseases and Hypertension, The University of Texas Health Sciences Center at Houston, Houston, TX, USA

References 

  1. Liang M, Knox FG. Production and functional roles of nitric oxide in the proximal tubule. Am J Physiol. 2000;278:R1117–R1124
  2. Wilcox CS, Deng X, Welch WJ. NO generation and action during changes in salt intake (Roles of nNOS and macula densa). Am J Physiol. 1998;274:R1588–R1593
  3. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis. 1997;30:311–333
  4. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol. 1997;272:F561–F578
  5. Babior BM. Phagocytes and oxidative stress. Am J Med. 2000;109:33–44
  6. Levonen AL, Patel RP, Brookes P, et al.  Mechanisms of cell signaling by nitric oxide and peroxynitrite (From mitochondria to MAP kinases). Antioxid Redox Signal. 2001;3:215–229
  7. Goto S, Yamamoto T, Feng L, et al.  Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol. 1995;147:1133–1141
  8. Narita I, Border WA, Ketteler M, et al.  Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest. 1995;72:17–24
  9. Jansen A, Cook T, Taylor GM, et al.  Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int. 1994;45:1215–1219
  10. Gabbai FB, Hammond TC, Thomson SC, et al.  Effect of acute iNOS inhibition on glomerular function in tubulointerstitial nephritis. Kidney Int. 2002;61:851–854
  11. Noiri E, Peresleni T, Miller F, et al.  In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest. 1996;97:2377–2383
  12. Noiri E, Nakao A, Uchida K, et al.  Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol. 2001;281:F948–F957
  13. Heyman SN, Goldfarb M, Carmeli F, et al.  Effect of radiocontrast agents on intrarenal nitric oxide (NO) and NO synthase activity. Exp Nephrol. 1998;6:557–562
  14. Fitzgerald J, Chou SY, Wahid A, et al.  Regional expression of inducible nitric oxide synthase in the kidney in dogs with unilateral ureteral obstruction. J Urol. 2001;166:1524–1529
  15. Joles JA, Vos IH, Grone HJ, et al.  Inducible nitric oxide synthase in renal transplantation. Kidney Int. 2002;61:872–875
  16. Romagnani P, Pupilli C, Lasagni L, et al.  Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol. 1999;187:345–350
  17. Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell. 2001;106:675–683
  18. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases (Structure, function and inhibition). Biochem J. 2001;357:593–615
  19. Tatoyan A, Giulivi C. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria. J Biol Chem. 1998;273:11044–11048
  20. Miller RT, Martasek P, Roman LJ, et al.  Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistry. 1997;36:15277–15284
  21. Crane BR, Arvai AS, Ghosh S, et al.  Structures of the N(omega)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. Biochemistry. 2000;39:4608–4621
  22. Li H, Raman CS, Glaser CB, et al.  Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. J Biol Chem. 1999;274:21276–21284
  23. Fischmann TO, Hruza A, Niu XD, et al.  Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999;6:233–242
  24. Ghosh S, Wolan D, Adak S, et al.  Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase. J Biol Chem. 1999;274:24100–24112
  25. Cubberley RR, Alderton WK, Boyhan A, et al.  Cysteine-200 of human inducible nitric oxide synthase is essential for dimerization of haem domains and for binding of haem, nitroarginine and tetrahydrobiopterin. Biochem J. 1997;323:141–146
  26. Ruan J, Xie Q, Hutchinson N, et al.  Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+. J Biol Chem. 1996;271:22679–22686
  27. Xie Q-W, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705–4708
  28. Boger RH, Bode-Boger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost. 2000;26:539–545
  29. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res. 1999;43:542–548
  30. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;5:88–97
  31. Crow JP, Beckman JS. Reactions between nitric oxide, superoxide, and peroxynitrite (footprints of peroxynitrite in vivo). Adv Pharmacol. 1995;34:17–43
  32. Ahn KY, Mohaupt MG, Madsen KM, et al.  In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol. 1994;267:F748–F757
  33. Mohaupt MG, Elzie JL, Ahn KY, et al.  Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 1994;46:653–665
  34. Morrissey JJ, McCracken R, Kaneto H, et al.  Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int. 1994;45:998–1005
  35. Wang T. Role of iNOS and eNOS in modulating proximal tubule transport and acid-base balance. Am J Physiol. 2002;283:F658–F662
  36. Terada Y, Tomita K, Nonoguchi H, et al.  Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest. 1992;90:659–666
  37. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol. 1995;268:F885–F898
  38. Wang X, Lu M, Gao Y, et al.  Neuronal nitric oxide synthase is expressed in principal cell of collecting duct. Am J Physiol. 1998;275:F395–F399
  39. Liu L, Liu GL, Barajas L. Distribution of nitric oxide synthase-containing ganglionic neuronal somata and postganglionic fibers in the rat kidney. J Comp Neurol. 1996;369:16–30
  40. Hall AV, Antoniou H, Wang Y, et al.  Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem. 1994;269:33082–33090
  41. Brenman JE, Xia H, Chao DS, et al.  Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci. 1997;19:224–231
  42. Xie J, Roddy P, Rife TK, et al.  Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci U S A. 1995;92:1242–1246
  43. Wang Y, Newton DC, Miller TL, et al.  An alternative promoter of the human neuronal nitric oxide synthase gene is expressed specifically in Leydig cells. Am J Pathol. 2002;160:369–380
  44. Sasaki M, Gonzalez-Zulueta M, Huang H, et al.  Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism. Proc Natl Acad Sci U S A. 2000;97:8617–8622
  45. Magee T, Fuentes AM, Garban H, et al.  Cloning of a novel neuronal nitric oxide synthase expressed in penis and lower urinary tract. Biochem Biophys Res Commun. 1996;226:145–151
  46. Silvagno F, Xia H, Bredt DS. Neuronal nitric oxide synthase-μ, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 1996;271:11204–11208
  47. Larsson B, Phillips SC. Isolation and characterization of a novel, human neuronal nitric oxide synthase cDNA. Biochem Biophys Res Commun. 1998;251:898–902
  48. Deans Z, Dawson SJ, Xie J, et al.  Differential regulation of the two neuronal nitric-oxide synthase gene promoters by the Oct-2 transcription factor. J Biol Chem. 1996;271:32153–32158
  49. Rife TK, Xie J, Redman C, et al.  The 5′2 promoter of the neuronal nitric oxide synthase dual promoter complex mediates inducibility by nerve growth factor. Brain Res Mol Brain Res. 2000;75:225–236
  50. Wei X, Sasaki M, Huang H, et al.  The orphan nuclear receptor, steroidogenic factor 1, regulates neuronal nitric oxide synthase gene expression in pituitary gonadotropes. Mol Endocrinol. 2002;16:2828–2839
  51. Wang Y, Goligorsky MS, Lin M, et al.  A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase. J Biol Chem. 1997;272:11392–11401
  52. Newton DC, Bevan SC, Choi S, et al.  Translational regulation of human neuronal nitric-oxide synthase by an alternatively spliced 5′-untranslated region leader exon. J Biol Chem. 2003;278:636–644
  53. Dawson TM, Steiner JP, Dawson VL, et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993;90:9808–9812
  54. Choi YB, Tenneti L, Le DA, et al.  Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci. 2000;3:15–21
  55. Komeima K, Watanabe Y. Dephosphorylation of nNOS at Ser(847) by protein phosphatase 2A. FEBS Lett. 2001;497:65–66
  56. Brenman JE, Chao DS, Xia H, et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 1995;82:743–752
  57. Brenman JE, Chao DS, Gee SH, et al.  Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 1996;84:757–767
  58. Brenman JE, Christopherson KS, Craven SE, et al.  Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neurosci. 1996;16:7407–7415
  59. Jaffrey SR, Snowman AM, Eliasson MJ, et al.  CAPON (A protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95). Neuron. 1998;20:115–124
  60. Riefler GM, Firestein BL. Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of CtBP from the nucleus to the cytosol (A novel function for targeting by the PDZ domain of nNOS). J Biol Chem. 2001;276:48262–48268
  61. Ort T, Maksimova E, Dirkx R, et al.  The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells. Eur J Cell Biol. 2000;79:621–630
  62. Schuh K, Uldrijan S, Telkamp M, et al.  The plasma membrane calmodulin-dependent calcium pump (A major regulator of nitric oxide synthase I). J Cell Biol. 2001;155:201–205
  63. Venema RC, Ju H, Zou R, et al.  Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem. 1997;272:1276–1282
  64. Venema VJ, Ju H, Zou R, et al.  Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem. 1997;272:28187–28190
  65. Garcia-Cardena G, Martasek P, Masters BS, et al.  Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem. 1997;272:25437–25440
  66. Jaffrey SR, Snyder SH. PIN (An associated protein inhibitor of neuronal nitric oxide synthase). Science. 1996;274:774–777
  67. Jeong Y, Won J, Yim J. Cloning and structure of a rabbit protein inhibitor of neuronal nitric oxide synthase (PIN) gene and its pseudogene. Gene. 1998;214:67–75
  68. Bender AT, Silverstein AM, Demady DR, et al.  Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo. J Biol Chem. 1999;274:1472–1478
  69. Golser R, Gorren AC, Leber A, et al.  Interaction of endothelial and neuronal nitric-oxide synthases with the bradykinin B2 receptor. Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. J Biol Chem. 2000;275:5291–5296
  70. Pupo AS, Minneman KP. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol. 2002;2:17
  71. Chartrain NA, Geller DA, Koty PP, et al.  Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem. 1994;269:6765–6772
  72. Eissa NT, Strauss AJ, Haggerty CM, et al.  Alternative splicing of human inducible nitric oxide synthase mRNA tissue specific regulation and induction by cytokines. J Biol Chem. 1996;271:27184–27187
  73. Eissa NT, Yuan JW, Haggerty CM, et al.  Cloning and characterization of human inducible nitric oxide synthase splice variants (A domain, encoded by exons 8 and 9, is critical for dimerization). Proc Natl Acad Sci U S A. 1998;95:7625–7630
  74. Guo FH, Comhair SA, Zheng S, et al.  Molecular mechanisms of increased nitric oxide (NO) in asthma (Evidence for transcriptional and post-translational regulation of NO synthesis). J Immunol. 2000;164:5970–5980
  75. De Vera ME, Taylor BS, Wang Q, et al.  Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol. 1997;273:G1290–G1296
  76. Marrero MB, Venema VJ, He H, et al.  Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells. Biochem Biophys Res Commun. 1998;252:508–512
  77. de Vera ME, Shapiro RA, Nussler AK, et al.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines (Initial analysis of the human NOS2 promoter). Proc Natl Acad Sci U S A. 1996;93:1054–1059
  78. Mellott JK, Nick HS, Waters MF, et al.  Cytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter. Am J Physiol. 2001;280:L390–L399
  79. Spitsin SV, Koprowski H, Michaels FH. Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol Med. 1996;2:226–235
  80. Linn SC, Morelli PJ, Edry I, et al.  Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol. 1997;272:G1499–G1508
  81. Nunokawa Y, Oikawa S, Tanaka S. Expression of human inducible nitric oxide synthase is regulated by both promoter and 3′-regions. Biochem Biophys Res Commun. 1997;233:523–526
  82. Taylor BS, de Vera ME, Ganster RW, et al.  Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem. 1998;273:15148–15156 [in process citation]
  83. Chu SC, Marks-Konczalik J, Wu HP, et al.  Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene (Characterization of differences between human and mouse iNOS promoters). Biochem Biophys Res Commun. 1998;248:871–878
  84. Ganster RW, Taylor BS, Shao L, et al.  Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci U S A. 2001;98:8638–8643
  85. Yu Z, Zhang W, Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol. 2002;13:2009–2017
  86. Rodriguez-Pascual F, Hausding M, Ihrig-Biedert I, et al.  Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem. 2000;275:26040–26049
  87. Carpenter L, Cordery D, Biden TJ. Protein kinase Cdelta activation by IL-1beta stabilizes inducible NO synthase mRNA in pancreatic beta-cells. J Biol Chem. 2000;276:5368–5374
  88. Gustafsson AB, Brunton L. β-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1β via message stabilization. Mol Pharmacol. 2000;58:1470–1478
  89. Saura M, Perez Sala D, Canada FJ, et al.  Role of tetrahydrobiopterin availability in the regulation of nitric oxide synthase expression in human mesangial cells. J Biol Chem. 1996;271:14290–14295
  90. Geng Y, Lotz M. Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability. J Cell Biol. 1995;129:1651–1657
  91. Kiemer AK, Vollmar AM. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem. 1998;273:13444–13451
  92. Perez-Sala D, Cernuda-Morollon E, Diaz-Cazorla M, et al.  Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol. 2001;280:F466–F473
  93. Pan J, Burgher KL, Szczepanik AM, et al.  Tyrosine phosphorylation of inducible nitric oxide synthase (Implications for potential post-translational regulation). Biochem J. 1996;314:889–894
  94. Kolodziejski PJ, Musial A, Koo JS, et al.  Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc Natl Acad Sci U S A. 2002;99:12315–12320
  95. Felley-Bosco E, Bender FC, Courjault-Gautier F, et al.  Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc Natl Acad Sci U S A. 2000;97:14334–14339
  96. Ratovitski EA, Bao C, Quick RA, et al.  An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J Biol Chem. 1999;274:30250–30257
  97. Ratovitski EA, Alam MR, Quick RA, et al.  Kalirin inhibition of inducible nitric-oxide synthase. J Biol Chem. 1999;274:993–999
  98. Kuncewicz T, Balakrishnan P, Snuggs MB, et al.  Specific association of nitric oxide synthase-2 with Rac isoforms in activated murine macrophages. Am J Physiol. 2001;281:F326–F336
  99. Glynne PA, Darling KE, Picot J, et al.  Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output. J Biol Chem. 2002;277:33132–33138
  100. Marsden PA, Heng HH, Scherer SW, et al.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478–17488
  101. Yoshimura M, Yasue H, Nakayama M, et al.  A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103:65–69
  102. Noiri E, Satoh H, Taguchi J, et al.  Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002;40:535–540
  103. Hingorani AD. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep. 2003;5:19–25
  104. Nassar BA, Bevin LD, Johnstone DE, et al.  Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J. 2001;142:586–589
  105. Zhang R, Min W, Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem. 1995;270:15320–15326
  106. Cieslik K, Zembowicz A, Tang JL, et al.  Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem. 1998;273:14885–14890
  107. Karantzoulis-Fegaras F, Antoniou H, Lai SL, et al.  Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem. 1999;274:3076–3093
  108. Laumonnier Y, Nadaud S, Agrapart M, et al.  Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem. 2000;275:40732–40741
  109. Teichert AM, Miller TL, Tai SC, et al.  In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. Am J Physiol. 2000;278:H1352–H1361
  110. Forstermann U, Boissel JP, Kleinert H. Expressional control of the “constitutive” isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12:773–790
  111. Kleinert H, Euchenhofer C, Fritz G, et al.  Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br J Pharmacol. 1998;123:1716–1722
  112. Kleinert H, Wallerath T, Euchenhofer C, et al.  Estrogens increase transcription of the human endothelial NO synthase gene (Analysis of the transcription factors involved). Hypertension. 1998;31:582–588
  113. Guillot PV, Guan J, Liu L, et al.  A vascular bed-specific pathway. J Clin Invest. 1999;103:799–805
  114. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998;273:24266–24271
  115. Drummond GR, Cai H, Davis ME, et al.  Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res. 2000;86:347–354
  116. Shaul PW, Smart EJ, Robinson LJ, et al.  Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996;271:6518–6522
  117. Liu JW, Garciacardena G, Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide (Implications for caveolae localization). Biochemistry. 1996;35:13277–13281
  118. Michel JB, Feron O, Sacks D, et al.  Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997;272:15583–15586
  119. Michel JB, Feron O, Sase K, et al.  Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem. 1997;272:25907–25912
  120. Feron O, Dessy C, Opel DJ, et al.  Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem. 1998;273:30249–30254
  121. Feron O, Saldana F, Michel JB, et al.  The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem. 1998;273:3125–3128
  122. Gratton JP, Fontana J, O’Connor DS, et al.  Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin-stimulated displacement of eNOS from caveolin-1. J Biol Chem. 2000;275:22268–22272
  123. Marrero MB, Venema VJ, Ju H, et al.  Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J. 1999;343:335–340
  124. Dedio J, Konig P, Wohlfart P, et al.  NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J. 2001;15:79–89
  125. Zimmermann K, Opitz N, Dedio J, et al.  NOSTRIN (A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase). Proc Natl Acad Sci U S A. 2002;99:17167–17172
  126. Cao S, Yao J, McCabe TJ, et al.  Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitric-oxide synthase function. J Biol Chem. 2001;276:14249–14256
  127. Chen ZP, Mitchelhill KI, Michell BJ, et al.  AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999;443:285–289
  128. Butt E, Bernhardt M, Smolenski A, et al.  Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem. 2000;275:5179–5187
  129. Harris MB, Ju H, Venema VJ, et al.  Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem. 2001;276:16587–16591
  130. Michell BJ, Griffiths MJ, Mitchelhill KI, et al.  The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol. 1999;9:845–848
  131. Luo Z, Fujio Y, Kureishi Y, et al.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest. 2000;106:493–499
  132. Fulton D, Gratton JP, McCabe TJ, et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597–601
  133. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000;407:538–541
  134. Igarashi J, Thatte HS, Prabhakar P, et al.  Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci U S A. 1999;96:12583–12588
  135. Igarashi J, Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem. 2000;275:32363–32370
  136. Cleeter MW, Cooper JM, Darley-Usmar VM, et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994;345:50–54
  137. Lizasoain I, Moro MA, Knowles RG, et al.  Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J. 1996;314:877–880
  138. Clementi E, Brown GC, Feelisch M, et al.  Persistent inhibition of cell respiration by nitric oxide (Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione). Proc Natl Acad Sci U S A. 1998;95:7631–7636
  139. Riobo NA, Clementi E, Melani M, et al.  Nitric oxide inhibits mitochondrial NADH (ubiquinone reductase activity through peroxynitrite formation). Biochem J. 2001;359:139–145
  140. Moncada S, Erusalimsky JD. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol. 2002;3:214–220
  141. Beltran B, Quintero M, Garcia-Zaragoza E, et al.  Inhibition of mitochondrial respiration by endogenous nitric oxide (A critical step in Fas signaling). Proc Natl Acad Sci U S A. 2002;99:8892–8897
  142. Beltran B, Mathur A, Duchen MR, et al.  The effect of nitric oxide on cell respiration (A key to understanding its role in cell survival or death). Proc Natl Acad Sci U S A. 2000;97:14602–14607
  143. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994;356:295–298
  144. Loke KE, McConnell PI, Tuzman JM, et al.  Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res. 1999;84:840–845
  145. Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide by mitochondria. J Biol Chem. 1998;273:11038–11043
  146. Elfering SL, Sarkela TM, Giulivi C. Biochemistry of mitochondrial nitric-oxide synthase. J Biol Chem. 2002;277:38079–38086
  147. Garvin JL, Hong NJ. Nitric oxide inhibits sodium/hydrogen exchange activity in the thick ascending limb. Am J Physiol. 1999;277:F377–F382
  148. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J. 1980;191:421–427
  149. Boveris A. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv Exp Med Biol. 1977;78:67–82
  150. Packer MA, Porteous CM, Murphy MP. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int. 1996;40:527–534
  151. Ortiz PA, Garvin JL. Interaction of O(2)(-) and NO in the thick ascending limb. Hypertension. 2002;39:591–596
  152. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol. 2002;283:F957–F962
  153. Halestrap AP, Doran E, Gillespie JP, et al.  Mitochondria and cell death. Biochem Soc Trans. 2000;28:170–177
  154. Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol. 2002;282:F777–F784
  155. Wang T, Inglis FM, Kalb RG. Defective fluid and HCO3− absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. Am J Physiol. 2000;279:F518–F524
  156. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 1996;270:F106–F115
  157. Guzman NJ, Fang MZ, Tang SS, et al.  Autocrine inhibition of Na+/K+-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest. 1995;95:2083–2088
  158. Linas SL, Repine JE. Endothelial cells regulate proximal tubule epithelial cell sodium transport. Kidney Int. 1999;55:1251–1258
  159. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl− cotransporter activity. Am J Physiol. 2001;281:F819–F825
  160. Ortiz PA, Garvin JL. Autocrine effects of nitric oxide on HCO3− transport by rat thick ascending limb. Kidney Int. 2000;58:2069–2074
  161. Plato CF, Stoos BA, Wang D, et al.  Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol. 1999;276:F159–F163
  162. Lu M, Wang X, Wang W. Nitric oxide increases the activity of the apical 70-pS K+ channel in TAL of rat kidney. Am J Physiol. 1998;274:F946–F950
  163. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 1995;6:89–94
  164. Garcia NH, Stoos BA, Carretero OA, et al.  Mechanism of the nitric oxide induced blockade of collecting duct water permeability. Hypertension. 1996;27:679–683
  165. Lu M, Giebisch G, Wang W. Nitric oxide links the apical Na+ transport to the basolateral K+ conductance in the rat cortical collecting duct. J Gen Physiol. 1997;110:717–726
  166. Lu M, Giebisch G, Wang W. Nitric oxide-induced hyperpolarization stimulates low-conductance Na+ channel of rat CCD. Am J Physiol. 1997;272:F498–F504
  167. Tojo A, Garg LC, Guzman NC, et al.  Nitric oxide inhibits bafilomycin-sensitive H+-ATPase activity in rat cortical collecting duct. Am J Physiol. 1994;267:F509–F515
  168. Wei Y, Wang W. Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts. Am J Physiol. 2003;284:F175–F181
  169. Majid DS, Navar LG. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens. 2001;14:74S–82S
  170. Ichihara A, Navar LG. Neuronal NOS contributes to biphasic autoregulatory response during enhanced TGF activity. Am J Physiol. 1999;277:F113–F120
  171. Majid DSA, Williams A, Navar LG. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs. Am J Physiol. 1993;264:F79–F87
  172. Mattson DL, Wu F. Control of arterial blood pressure and renal sodium excretion by nitric oxide synthase in the renal medulla. Acta Physiol Scand. 2000;168:149–154
  173. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688–692
  174. Mattson DL, Lu S, Nakanishi K, et al.  Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918–H1926
  175. Zou AP, Cowley AW. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension. 1997;29:194–198
  176. Szentivanyi M, Zou AP, Mattson DL, et al.  Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol. 2002;283:R266–R272
  177. Majid DS, Godfrey M, Grisham MB, et al.  Relation between pressure natriuresis and urinary excretion of nitrate/nitrite in anesthetized dogs. Hypertension. 1995;25:860–865
  178. Wilcox CS, Welch WJ. Macula densa nitric oxide synthase (Expression, regulation, and function). Kidney Int. 1998;67(Suppl):S53–S57
  179. Thorup C, Persson AEG. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Acta Physiol Scand. 1995;153:43–49
  180. Wilcox CS, Welch WJ, Murad F, et al.  Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A. 1992;89:11993–11997
  181. Schnermann J, Traynor T, Yang T, et al.  Tubuloglomerular feedback (New concepts and developments). Kidney Int. 1998;67(Suppl):S40–S45
  182. Wilcox CS, Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand. 2000;168:119–124
  183. Welch WJ, Tojo A, Lee JU, et al.  Nitric oxide synthase in the JGA of the SHR (Expression and role in tubuloglomerular feedback). Am J Physiol. 1999;277:F130–F138
  184. Wang H, Carretero OA, Garvin JL. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension. 2002;39:662–666
  185. Tojo A, Bredt DS, Wilcox CS. Distribution of postsynaptic density proteins in rat kidney (Relationship to neuronal nitric oxide synthase). Kidney Int. 1999;55:1384–1394
  186. Roczniak A, Zimpelmann J, Burns KD. Effect of dietary salt on neuronal nitric oxide synthase in the inner medullary collecting duct. Am J Physiol. 1998;275:F46–F54
  187. Huang PL, Dawson TM, Bredt DS, et al.  Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993;75:1273–1286
  188. Demas GE, Eliasson MJ, Dawson TM, et al.  Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice. Mol Med. 1997;3:610–616
  189. Sutherland RS, Kogan BA, Piechota HJ, et al.  Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. J Urol. 1997;157:1109–1116
  190. Huang Z, Huang PL, Panahian N, et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883–1885
  191. Morishita T, Tsutsui M, Shimokawa H, et al.  Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J. 2002;16:1994–1996
  192. Vallon V, Traynor T, Barajas L, et al.  Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol. 2001;12:1599–1606
  193. Ling H, Edelstein C, Gengaro P, et al.  Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol. 1999;277:F383–F390
  194. Ling H, Gengaro PE, Edelstein CL, et al.  Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int. 1998;53:1642–1646
  195. Gross SS, Kilbourn RG, Griffith OW. NO in septic shock: Good, bad or ugly? Learning from iNOS knockouts. Trends Microbiol. 1996;4:47–49
  196. Guo Y, Jones WK, Xuan YT, et al.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A. 1999;96:11507–11512
  197. Chyu KY, Dimayuga P, Zhu J, et al.  Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res. 1999;85:1192–1198
  198. Plato CF, Shesely EG, Garvin JL. eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux. Hypertension. 2000;35:319–323
  199. Duplain H, Burcelin R, Sartori C, et al.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342–345
  200. Huang Z, Huang PL, Ma J, et al.  Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab. 1996;16:981–987
  201. Feng Q, Song W, Lu X, et al.  Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation. 2002;106:873–879
  202. Lee TC, Zhao YD, Courtman DW, et al.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation. 2000;101:2345–2348
  203. Fagan KA, McMurtry I, Rodman DM. Nitric oxide synthase in pulmonary hypertension (Lessons from knockout mice). Physiol Res. 2000;49:539–548
  204. Fukumura D, Gohongi T, Kadambi A, et al.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98:2604–2609

PII: S0270-9295(04)00050-6

doi: 10.1016/j.semnephrol.2004.04.002

Seminars in Nephrology
Volume 24, Issue 4 , Pages 299-315 , July 2004

Article Tools

* Image Usage & Resolution